Halberd Corporation (HALB)

Intra-Cellular Therapies Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2021	FY 2020	FY 2011	FY 2010	FY 2009
Period Ending	Apr 30, 2022	Jul 31, 2021	Jul 31, 2020	Jul 31, 2011	Jul 31, 2010	Jul 31, 2009
Net Income	-1.71	-0.96	-1.65	0.18	-0.32	-1.21
Depreciation & Amortization	0	-	-	0	0.01	0
Asset Writedown & Restructuring Costs	-	-	-	-	-	0.5
Stock-Based Compensation	0.48	0.02	1.6	-	0.06	0.25
Other Operating Activities	-	-	-	-	-	0.02
Change in Accounts Receivable	-	-	-	-0.02	-0.03	-
Change in Inventory	-	-	-	-0.09	-	-
Change in Accounts Payable	0.19	0.17	0.01	-0.05	0.05	0.4
Change in Unearned Revenue	-	-	-	-	-	0
Change in Other Net Operating Assets	0.02	-0.01	-0	-	0.02	0.14
Operating Cash Flow	-1.02	-0.79	-0.04	0.01	-0.21	0.1
Operating Cash Flow Growth	-	-	-	-	-	569.17%
Capital Expenditures	-0.01	-0	-	-0	-	-0.25
Sale (Purchase) of Intangibles	-	-	-	-	-	-0.01
Investing Cash Flow	-0.01	-0	-	-0	-	-0.26
Short-Term Debt Issued	-	-	-	-	0	0.06
Long-Term Debt Issued	-	0.15	-	-	0.29	0.02
Total Debt Issued	-	0.15	-	-	0.29	0.08
Short-Term Debt Repaid	-	-	-	-0.01	-0.08	-
Total Debt Repaid	-	-	-	-0.01	-0.08	-
Net Debt Issued (Repaid)	-	0.15	-	-0.01	0.21	0.08
Issuance of Common Stock	0.93	0.67	0.04	-	-	0.09
Other Financing Activities	-	-	-	-	-	-0.01
Financing Cash Flow	0.93	0.82	0.04	-0.01	0.21	0.16
Net Cash Flow	-0.1	0.04	0	0	-0	0
Free Cash Flow	-1.03	-0.79	-0.04	0.01	-0.21	-0.15
Free Cash Flow Margin	-14805.32%	-15016.80%	-	15.10%	-631.03%	-1936.08%
Free Cash Flow Per Share	-0.00	-0.00	-	-	-0.01	-0.01
Cash Interest Paid	0	0.02	-	-	0	0.01
Levered Free Cash Flow	-	-0.5	-	-0.5	-	-0.21
Unlevered Free Cash Flow	-	-0.49	-	-0.45	-	-0.18
Change in Net Working Capital	-	-0.08	-	0.48	-	-0.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.